Neogen (NEOG) Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Neogen in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NEOG shares.
View NEOG analyst ratings or view top-rated stocks.

2 Wall Street research analysts have issued 1-year target prices for Neogen's stock. Their NEOG share price forecasts range from $19.00 to $19.00. On average, they predict the company's stock price to reach $19.00 in the next twelve months. This suggests a possible upside of 2.3% from the stock's current price.
View analysts price targets for NEOG or view top-rated stocks among Wall Street analysts.

Neogen's stock was trading at $15.23 on January 1st, 2023. Since then, NEOG shares have increased by 21.9% and is now trading at $18.57.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 25th 2023.
View our NEOG earnings forecast.

Neogen Co. (NASDAQ:NEOG) announced its quarterly earnings results on Thursday, March, 30th. The company reported $0.12 EPS for the quarter, topping analysts' consensus estimates of $0.04 by $0.08. The business had revenue of $218.30 million for the quarter, compared to analysts' expectations of $218.87 million. Neogen had a negative net margin of 1.87% and a positive trailing twelve-month return on equity of 4.64%. Neogen's revenue was up 70.3% on a year-over-year basis. During the same period last year, the firm earned $0.13 earnings per share.

ETFs with the largest weight of Neogen (NASDAQ:NEOG) stock in their portfolio include iShares Emergent Food and AgTech Multisector ETF (IVEG), SPDR S&P Health Care Equipment ETF (XHE), VanEck Agribusiness ETF (MOO), ProShares MSCI Transformational Changes ETF (ANEW), Franklin U.S. Small Cap Multifactor Index ETF (FLQS), SPDR S&P 400 Mid Cap Value ETF (MDYV), First Trust Multi-Manager Small Cap Opportunities ETF (MMSC) and iShares S&P Mid-Cap 400 Value ETF (IJJ).

Neogen's stock split on Tuesday, January 2nd 2018. The 4-3 split was announced on Friday, December 8th 2017. The newly minted shares were issued to shareholders after the market closes on Friday, December 29th 2017. An investor that had 100 shares of stock prior to the split would have 133 shares after the split.

Neogen issued an update on its FY 2025 earnings guidance on Wednesday, June, 7th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.00 billion-$1.00 billion.

31 employees have rated Neogen Chief Executive Officer John Adent on Glassdoor.com. John Adent has an approval rating of 56% among the company's employees. This puts John Adent in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Neogen investors own include NVIDIA (NVDA), NIKE (NKE), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Boeing (BA), JPMorgan Chase & Co. (JPM), W. P. Carey (WPC), Advanced Micro Devices (AMD) and Costco Wholesale (COST).

Neogen trades on the NASDAQ under the ticker symbol "NEOG."

Neogen's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (11.27%), Wasatch Advisors LP (6.54%), Select Equity Group L.P. (3.69%), State Street Corp (3.50%), Brown Capital Management LLC (2.70%) and King Luther Capital Management Corp (2.68%). Insiders that own company stock include Bruce Papesh, Darci L Vetter, Douglas Edward Jones, James L Herbert, James P Tobin, Jason Warren Lilly, John Edward Adent, Ronald D Green, Steven J Quinlan, Terri A Morrical and William T Boehm.
View institutional ownership trends.

Shares of NEOG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NEOG stock can currently be purchased for approximately $18.57.

Neogen (NASDAQ:NEOG) has a market capitalization of $4.02 billion and generates $527.16 million in revenue each year. The company earns $48.31 million in net income (profit) each year or $0.04 on an earnings per share basis.

The company employs 2,108 workers across the globe.

Neogen's mailing address is 620 LESHER PLACE, LANSING MI, 48912. The official website for the company is www.neogen.com. The company can be reached via phone at (517) 372-9200, via email at ir@neogen.com, or via fax at 517-372-2006.